tiprankstipranks
Trending News
More News >
Noile-Immune Biotech Inc. (JP:4893)
:4893
Japanese Market

Noile-Immune Biotech Inc. (4893) Revenue

Compare
0 Followers

Noile-Immune Biotech Inc. Revenue

Noile-Immune Biotech Inc. had a revenue of 2.00M in the quarter ending Dec 31, 2024, with -33.33%. This bring the company's revenue in the last twelve months to 7.59M, Increased -8.16%. In the fiscal year ending Dec 31, 2024, Noile-Immune Biotech Inc. had annual revenue of 7.59M with -97.61% growth.
Revenue (ttm)
7.59M
Revenue Growth
-97.61%
P/S Ratio
1021.03
Revenue/Employee
¥303,480
Employees
25
Market Cap
¥7.75B

Revenue Chart

Revenue History
Fiscal End Date
Revenue
Change
Growth
Dec 31, 2024
7.59M-309.23M-97.61%
Dec 31, 2023
316.82M-308.96M-49.37%
Dec 31, 2022
625.78M525.05M+521.24%
Dec 31, 2021
100.73M3.46M+3.55%
Dec 31, 2020
97.28M
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis